Attributes | Values |
---|
rdf:type
| |
http://linked.open...gbank/description
| - Butalbital, 5-allyl-5-isobutylbarbituric acid, is a barbiturate with an intermediate duration of action. It has the same chemical formula as talbutal but a different structure. Butalbital is often combined with other medications, such as acetaminophen or aspirin, and is commonly prescribed for the treatment of pain and headache. [Wikipedia] (en)
|
http://linked.open...gy/drugbank/group
| - approved (en)
- illicit (en)
|
http://linked.open...drugbank/halfLife
| |
http://linked.open...ugbank/indication
| - Used in combination with acetaminophen or aspirin and caffeine for its sedative and relaxant effects in the treatment of tension headaches, migraines, and pain. (en)
|
sameAs
| |
Title
| |
adms:identifier
| |
http://linked.open...mechanismOfAction
| - Butalbital binds at a distinct binding site associated with a Cl<sup>-</sup> ionopore at the GABA<sub>A</sub> receptor, increasing the duration of time for which the Cl<sup>-</sup> ionopore is open. The post-synaptic inhibitory effect of GABA in the thalamus is, therefore, prolonged. (en)
|
http://linked.open...drugbank/packager
| |
http://linked.open.../drugbank/synonym
| - allylbarbital (en)
- 5-Allyl-5-(2'-methyl-N-propyl) barbituric acid (en)
- 5-Allyl-5-(2-methylpropyl)barbituric acid (en)
- 5-Allyl-5-isobutyl-pyrimidine-2,4,6-trione (en)
- 5-Allyl-5-isobutylbarbituric acid (en)
- 5-isobutyl-5-allylbarbituric acid (en)
- Allylbarbituric acid (en)
- Butalbarbital (en)
- Butalbitalum (en)
- Iso-butylallylbarbituric acid (en)
- Itobarbital (en)
- Tetrallobarbital (en)
- allylbarbitone (en)
- 5-Allyl-5-isobutyl-2,4,6(1H,3H,5H)-pyrimidinetrione (en)
- 5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione (en)
|
http://linked.open...drugbank/toxicity
| - Symptoms of acute barbiturate poisoning include drowsiness, confusion, coma, respiratory depression, hypotension, and shock. (en)
|
http://linked.open.../drugbank/mixture
| |
http://linked.open...nk/proteinBinding
| |
http://linked.open...y/mesh/hasConcept
| |
foaf:page
| |
http://linked.open...ugbank/IUPAC-Name
| |
http://linked.open...gy/drugbank/InChI
| |
http://linked.open...Molecular-Formula
| |
http://linked.open.../Molecular-Weight
| |
http://linked.open...noisotopic-Weight
| |
http://linked.open...y/drugbank/SMILES
| |
http://linked.open.../Water-Solubility
| |
http://linked.open...ogy/drugbank/logP
| |
http://linked.open...ogy/drugbank/logS
| |
http://linked.open...nd-Acceptor-Count
| |
http://linked.open...-Bond-Donor-Count
| |
http://linked.open...drugbank/InChIKey
| |
http://linked.open...urface-Area--PSA-
| |
http://linked.open...nk/Polarizability
| |
http://linked.open...bank/Refractivity
| |
http://linked.open...atable-Bond-Count
| |
http://linked.open...ugbank/absorption
| - Well absorbed from the gastrointestinal tract and is expected to distribute to most tissues in the body. (en)
|
http://linked.open.../affectedOrganism
| - Humans and other mammals (en)
|
http://linked.open...casRegistryNumber
| |
http://linked.open...gbank/containedIn
| |